Application

17740192 · OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF

Filed 2022-05-09 · Granted · Patent 11957784 (2024-04-16) The official file ↗The patent and its PDF ↗ · Art unit 1617 · Examiner Alma Pipic Typical · CPC A61K 9/0048 · Mati Therapeutics, Inc. · Mati Therapeutics Inc.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

8.0 mo

to disposition 23.3 mo

Statutes raised

112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.